Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

CONCLUSIONS: RLP-C is useful for risk assessment of future cardiovascular events in patients having type 2 DM and CKD.
PMID: 27256217 [PubMed - as supplied by publisher]

Source: Journal of Cardiology - May 29, 2016 Category: Cardiology Authors: Nguyen SV, Nakamura T, Uematsu M, Fujioka D, Watanabe K, Watanabe Y, Obata JE, Nakamura K, Kugiyama K Tags: J Cardiol Source Type: research